1. Home
  2. ALCO vs LCTX Comparison

ALCO vs LCTX Comparison

Compare ALCO & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

HOLD

Current Price

$39.70

Market Cap

297.3M

Sector

N/A

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$0.93

Market Cap

255.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALCO
LCTX
Founded
1960
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.3M
255.4M
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
ALCO
LCTX
Price
$39.70
$0.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
★ $44.00
$6.25
AVG Volume (30 Days)
14.4K
★ 1.1M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
★ 0.49%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.32
N/A
Revenue
N/A
★ $14,556,000.00
Revenue This Year
N/A
$109.40
Revenue Next Year
N/A
N/A
P/E Ratio
$29.86
★ N/A
Revenue Growth
N/A
★ 53.24
52 Week Low
$31.32
$0.96
52 Week High
$45.01
$2.09

Technical Indicators

Market Signals
Indicator
ALCO
LCTX
Relative Strength Index (RSI) 51.02 36.60
Support Level $37.31 N/A
Resistance Level $40.13 $1.18
Average True Range (ATR) 0.81 0.06
MACD -0.01 -0.01
Stochastic Oscillator 68.51 6.30

Price Performance

Historical Comparison
ALCO
LCTX

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: